Physiology and pathophysiology of organic acids in cerebrospinal fluid

Concentrations of organic acids in cerebrospinal fluid (CSF) appear to be directly dependent upon their rate of production in the brain. There is evidence that the net release of short-chain monocarboxylic acids from the brain is a major route for removing these products of cerebral metabolism. Conc...

Full description

Saved in:
Bibliographic Details
Published inJournal of inherited metabolic disease Vol. 16; no. 4; p. 648
Main Authors Hoffmann, G F, Meier-Augenstein, W, Stöckler, S, Surtees, R, Rating, D, Nyhan, W L
Format Journal Article
LanguageEnglish
Published United States 01.01.1993
Subjects
Online AccessGet more information

Cover

Loading…
Abstract Concentrations of organic acids in cerebrospinal fluid (CSF) appear to be directly dependent upon their rate of production in the brain. There is evidence that the net release of short-chain monocarboxylic acids from the brain is a major route for removing these products of cerebral metabolism. Concentrations of organic acids in blood and CSF are largely independent of each other. Quantitative reference values for the concentrations of organic acids in CSF and plasma as well as ratios of individual organic acids between CSF and plasma were determined in 35 pairs of samples from paediatric patients. Over 25 organic acids were quantifiable in all or in the majority of CSF and/or plasma specimens (limit of detection 1 mumol/L). There were substantial differences in the CSF/plasma ratios between subgroups of organic acids. Metabolites related to fatty-acid oxidation were present in CSF in substantially less amounts than in plasma. Organic acids related to carbohydrate and energy metabolism and to amino acid degradation were present in CSF in the same amounts as or slightly smaller amounts than in plasma. Finally, some organic acids were found in substantially higher amounts in CSF than in plasma, e.g. glycolate, glycerate, 2,4-dihydroxybutyrate, citrate and isocitrate. Studies of organic acids in CSF and plasma samples are presented from patients with 'cerebral' lactic acidosis, disorders of propionate and methylmalonate metabolism, glutaryl-CoA dehydrogenase deficiency and L-2-hydroxy-glutaric aciduria. It became apparent that derangements of organic acids in the CSF may occur independently of the systemic metabolism. Quantitative organic acid analysis in CSF will yield new information on the pathophysiology in the central nervous system (CNS) of these disorders and may prove necessary for successful monitoring of treatment of organoacidopathies, which present mainly with neurological disease. For example, in glutaryl-CoA dehydrogenase deficiency the urinary excretion of glutarate appears to be an inadequate parameter for monitoring the effect of dietary therapy, without plasma and CSF determinations. In L-2-hydroxyglutaric aciduria the elevation of L-2-hydroxyglutarate was found to be greater in CSF than in plasma. In addition, some other organic acids, glycolate, glycerate, 2,4-dihydroxybutyrate, citrate and isocitrate, were also elevated in the CSF of the patients out of proportion to normal levels in plasma and urine. High concentrations of an unknown compound, which was tentatively identified as 2,4-dihydroxyglutarate, were found in the CSF of patients with L-2-hydroxyglutaric aciduria.
AbstractList Concentrations of organic acids in cerebrospinal fluid (CSF) appear to be directly dependent upon their rate of production in the brain. There is evidence that the net release of short-chain monocarboxylic acids from the brain is a major route for removing these products of cerebral metabolism. Concentrations of organic acids in blood and CSF are largely independent of each other. Quantitative reference values for the concentrations of organic acids in CSF and plasma as well as ratios of individual organic acids between CSF and plasma were determined in 35 pairs of samples from paediatric patients. Over 25 organic acids were quantifiable in all or in the majority of CSF and/or plasma specimens (limit of detection 1 mumol/L). There were substantial differences in the CSF/plasma ratios between subgroups of organic acids. Metabolites related to fatty-acid oxidation were present in CSF in substantially less amounts than in plasma. Organic acids related to carbohydrate and energy metabolism and to amino acid degradation were present in CSF in the same amounts as or slightly smaller amounts than in plasma. Finally, some organic acids were found in substantially higher amounts in CSF than in plasma, e.g. glycolate, glycerate, 2,4-dihydroxybutyrate, citrate and isocitrate. Studies of organic acids in CSF and plasma samples are presented from patients with 'cerebral' lactic acidosis, disorders of propionate and methylmalonate metabolism, glutaryl-CoA dehydrogenase deficiency and L-2-hydroxy-glutaric aciduria. It became apparent that derangements of organic acids in the CSF may occur independently of the systemic metabolism. Quantitative organic acid analysis in CSF will yield new information on the pathophysiology in the central nervous system (CNS) of these disorders and may prove necessary for successful monitoring of treatment of organoacidopathies, which present mainly with neurological disease. For example, in glutaryl-CoA dehydrogenase deficiency the urinary excretion of glutarate appears to be an inadequate parameter for monitoring the effect of dietary therapy, without plasma and CSF determinations. In L-2-hydroxyglutaric aciduria the elevation of L-2-hydroxyglutarate was found to be greater in CSF than in plasma. In addition, some other organic acids, glycolate, glycerate, 2,4-dihydroxybutyrate, citrate and isocitrate, were also elevated in the CSF of the patients out of proportion to normal levels in plasma and urine. High concentrations of an unknown compound, which was tentatively identified as 2,4-dihydroxyglutarate, were found in the CSF of patients with L-2-hydroxyglutaric aciduria.
Author Hoffmann, G F
Rating, D
Surtees, R
Nyhan, W L
Stöckler, S
Meier-Augenstein, W
Author_xml – sequence: 1
  givenname: G F
  surname: Hoffmann
  fullname: Hoffmann, G F
  organization: Department of Pediatrics, University of Heidelberg, Germany
– sequence: 2
  givenname: W
  surname: Meier-Augenstein
  fullname: Meier-Augenstein, W
– sequence: 3
  givenname: S
  surname: Stöckler
  fullname: Stöckler, S
– sequence: 4
  givenname: R
  surname: Surtees
  fullname: Surtees, R
– sequence: 5
  givenname: D
  surname: Rating
  fullname: Rating, D
– sequence: 6
  givenname: W L
  surname: Nyhan
  fullname: Nyhan, W L
BackLink https://www.ncbi.nlm.nih.gov/pubmed/8412012$$D View this record in MEDLINE/PubMed
BookMark eNpFj81KAzEURrOo1La6cS_kBUZvMjeTZKnFUaGgC12X_LaRaTJM7KJvr2DBzXfgLA58SzLLJQdCbhjcMQB5_9j_LmNKqxlZAEPWKC3EJVnW-gUAWgkxJ3OFjAPjC9K_7081laHsTtRkT0fzvS_jvyuRlmlncnLUuOQrTZm6MAU7lTqmbAYah2PyV-QimqGG6zNX5LN_-li_NJu359f1w6ZxyJRqrPXSYOwCekAB1oMXnTdCc45opZSGiVb6loPVGlkXwUEbMVp0Qcbg-Irc_nXHoz0Evx2ndDDTaXv-w38A30pMLw
CitedBy_id crossref_primary_10_1002_jimd_12599
crossref_primary_10_1016_S0378_4347_98_00136_4
crossref_primary_10_1016_j_expneurol_2005_09_002
crossref_primary_10_1007_s11306_019_1571_9
crossref_primary_10_1023_A_1015165212965
crossref_primary_10_1002_jimd_12636
crossref_primary_10_1016_S0197_0186_05_80011_7
crossref_primary_10_1016_j_taap_2022_116143
crossref_primary_10_3390_nutraceuticals1010006
crossref_primary_10_1038_s41467_021_22272_3
crossref_primary_10_15252_embr_201338064
crossref_primary_10_1016_S0925_4439_01_00088_6
crossref_primary_10_1172_JCI34138
crossref_primary_10_1002_jnr_10735
crossref_primary_10_1007_s10545_006_0415_8
crossref_primary_10_1016_j_molcel_2018_04_011
crossref_primary_10_20538_1682_0363_2012_1_128_134
crossref_primary_10_3109_00498254_2013_791410
crossref_primary_10_1007_s10571_022_01236_1
crossref_primary_10_1016_j_chroma_2007_11_047
crossref_primary_10_1016_j_ijdevneu_2005_10_005
crossref_primary_10_1016_j_carres_2006_06_023
crossref_primary_10_1016_S0957_5839_05_80060_0
crossref_primary_10_1016_j_brainres_2009_08_080
crossref_primary_10_1021_acscentsci_8b00879
crossref_primary_10_1016_j_ymgme_2018_06_008
crossref_primary_10_1021_ac801185e
crossref_primary_10_1203_00006450_199609000_00007
crossref_primary_10_1038_s41598_023_41765_3
crossref_primary_10_1371_journal_pone_0181758
crossref_primary_10_1016_j_tibs_2015_01_004
crossref_primary_10_1111_jnc_14693
crossref_primary_10_1016_j_ijdevneu_2008_07_011
crossref_primary_10_1093_hmg_ddh300
crossref_primary_10_1016_S0006_8993_98_00563_0
crossref_primary_10_3390_ijms21239137
crossref_primary_10_1007_s11011_010_9190_1
crossref_primary_10_1007_s11064_006_9054_6
crossref_primary_10_1002_rcm_4156
crossref_primary_10_1016_0006_8993_96_00117_5
crossref_primary_10_1016_j_neuint_2010_04_002
crossref_primary_10_1016_j_ymben_2022_12_008
crossref_primary_10_1021_acs_chemrev_1c00746
crossref_primary_10_1213_ANE_0000000000005926
crossref_primary_10_1186_s12877_024_04759_y
crossref_primary_10_1007_s11064_016_2154_z
crossref_primary_10_1002_mrd_23082
crossref_primary_10_1007_BF02815059
crossref_primary_10_1016_j_brainres_2010_02_018
crossref_primary_10_1007_BF01955272
crossref_primary_10_1007_s11306_013_0582_1
crossref_primary_10_1016_j_expneurol_2006_04_004
crossref_primary_10_1016_j_taap_2018_03_017
crossref_primary_10_1007_s10545_006_9998_3
crossref_primary_10_1016_j_jchromb_2014_01_041
crossref_primary_10_1016_S0006_8993_97_00415_0
crossref_primary_10_3390_ijms231911693
crossref_primary_10_1016_j_ymgme_2021_03_017
crossref_primary_10_1016_0378_4347_95_00115_Y
crossref_primary_10_1016_j_mam_2009_12_006
crossref_primary_10_1007_s12035_015_9289_9
crossref_primary_10_1016_j_jchromb_2020_121982
crossref_primary_10_15583_jpchrom_2022_011
crossref_primary_10_1016_j_jns_2005_12_005
crossref_primary_10_1016_j_chroma_2013_04_005
crossref_primary_10_1002_dta_3399
crossref_primary_10_1038_s41380_022_01752_y
crossref_primary_10_1016_j_jpba_2021_114450
crossref_primary_10_3390_jcm6070071
crossref_primary_10_1007_s11064_005_7711_9
crossref_primary_10_1021_acschemneuro_1c00119
crossref_primary_10_1016_j_brainres_2004_10_010
crossref_primary_10_1016_S0192_0561_97_85559_2
crossref_primary_10_1007_s11011_009_9131_z
crossref_primary_10_1016_j_clinms_2019_11_002
crossref_primary_10_1016_j_lfs_2007_12_024
crossref_primary_10_1007_s12640_018_9874_6
crossref_primary_10_1007_BF00711767
crossref_primary_10_1016_j_jns_2003_10_005
crossref_primary_10_1007_BF00970591
crossref_primary_10_1007_s10571_011_9675_4
crossref_primary_10_1016_j_pain_2013_10_005
crossref_primary_10_1002_jcp_30981
crossref_primary_10_1007_s00216_006_0911_6
crossref_primary_10_1007_s11011_012_9327_5
crossref_primary_10_1016_j_neuroscience_2016_10_049
crossref_primary_10_1016_j_ijdevneu_2009_08_004
crossref_primary_10_1016_S0006_8993_03_02722_7
crossref_primary_10_1016_j_toxlet_2018_06_1070
crossref_primary_10_1007_BF02138786
crossref_primary_10_1016_j_jns_2007_04_011
crossref_primary_10_1186_gm337
crossref_primary_10_3390_metabo12070610
crossref_primary_10_1016_j_neuint_2015_11_005
crossref_primary_10_1016_j_ymgme_2011_10_003
crossref_primary_10_1007_s10863_011_9330_2
crossref_primary_10_1006_exnr_1997_6602
crossref_primary_10_1007_s10571_012_9879_2
crossref_primary_10_1016_j_ntt_2006_04_003
crossref_primary_10_1021_bi200499m
crossref_primary_10_1039_b913468a
crossref_primary_10_1186_s13195_017_0303_5
crossref_primary_10_1016_j_jpba_2022_114738
crossref_primary_10_1134_S1054661814020151
crossref_primary_10_3390_metabo11120835
crossref_primary_10_1016_j_clinbiochem_2019_04_004
crossref_primary_10_1016_j_jchromb_2023_123719
crossref_primary_10_1016_j_neuint_2010_03_009
crossref_primary_10_1016_j_xphs_2021_01_025
crossref_primary_10_1016_S0197_0186_01_00130_9
crossref_primary_10_1016_j_jchromb_2008_05_001
crossref_primary_10_1371_journal_pone_0053735
crossref_primary_10_1002_jmri_10270
crossref_primary_10_1007_s11011_007_9046_5
crossref_primary_10_1007_s11011_006_9041_2
crossref_primary_10_1016_j_ijdevneu_2010_10_007
crossref_primary_10_1097_RMR_0b013e31804c99d4
crossref_primary_10_17116_jnevro201611612196_103
crossref_primary_10_1016_S0021_9673_97_00317_8
crossref_primary_10_1007_s10545_007_0798_1
crossref_primary_10_1007_s11011_010_9204_z
crossref_primary_10_1073_pnas_1603023113
crossref_primary_10_1016_j_neuroscience_2021_07_024
crossref_primary_10_1007_s12035_022_02930_3
crossref_primary_10_1177_197140090001300513
crossref_primary_10_15583_jpchrom_2023_015
crossref_primary_10_1038_tp_2011_55
crossref_primary_10_1016_j_neuropharm_2016_05_006
crossref_primary_10_1186_1750_1172_8_98
crossref_primary_10_3390_cells10123388
crossref_primary_10_1016_S0022_3476_95_70208_3
crossref_primary_10_1016_j_lfs_2008_04_015
crossref_primary_10_1039_C6MB00424E
crossref_primary_10_1023_A_1005359416197
crossref_primary_10_1007_s11306_010_0250_7
crossref_primary_10_1016_j_mrgentox_2010_07_008
crossref_primary_10_1246_cl_150153
crossref_primary_10_1007_s11011_013_9396_0
crossref_primary_10_1111_bjh_18307
crossref_primary_10_1590_S0100_879X2001000500010
crossref_primary_10_1007_s10545_009_1197_6
crossref_primary_10_1007_s11011_006_9002_9
crossref_primary_10_1590_S0100_879X2001000200010
crossref_primary_10_1002_jnr_21527
crossref_primary_10_1093_jnen_nlw121
crossref_primary_10_3389_fmolb_2021_682134
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1007/BF00711898
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
ExternalDocumentID 8412012
Genre Research Support, U.S. Gov't, P.H.S
Review
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: NINDS NIH HHS
  grantid: NS22343
GroupedDBID ---
-53
-5E
-5G
-BR
-Y2
-~C
.55
.86
.GJ
.VR
06C
06D
0R~
0VY
199
1N0
1OB
1OC
1SB
2.D
203
28-
29K
29~
2J2
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
33P
3SX
3V.
4.4
408
409
40D
40E
53G
5GY
5QI
5RE
5VS
67Z
6NX
78A
7X7
88E
8AO
8FI
8FJ
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AAHHS
AAIAL
AAJKR
AANLZ
AANXM
AARHV
AARTL
AASGY
AATVU
AAWCG
AAXRX
AAYIU
AAYQN
AAYTO
AAYZH
ABBBX
ABBXA
ABCUV
ABHLI
ABIPD
ABJOX
ABKTR
ABMNI
ABNWP
ABPLI
ABPPZ
ABQBU
ABQWH
ABTEG
ABTMW
ABUWG
ABUWZ
ACAHQ
ACBXY
ACCFJ
ACCZN
ACGFS
ACHXU
ACKNC
ACOKC
ACOMO
ACPOU
ACPRK
ACUDM
ACXBN
ACXQS
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADKPE
ADKYN
ADMGS
ADOZA
ADRFC
ADXAS
ADZKW
ADZMN
AEBTG
AEEZP
AEFIE
AEGAL
AEGNC
AEIGN
AEJHL
AEKMD
AENEX
AEOHA
AEPYU
AEQDE
AETLH
AEUYR
AEXYK
AFBBN
AFEXP
AFFNX
AFFPM
AFGKR
AFKRA
AFLOW
AFWTZ
AFZKB
AGAYW
AGGDS
AGJBK
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBTC
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIIXL
AITYG
AIURR
AIWBW
AJBDE
AJBLW
AJRNO
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALWAN
AMKLP
AMYDB
AMYQR
ARMRJ
ASPBG
AVWKF
AZFZN
B-.
BA0
BBWZM
BDATZ
BENPR
BFHJK
BGNMA
BPHCQ
BVXVI
C45
CAG
CCPQU
CGR
COF
CS3
CSCUP
CUY
CVF
D-I
DCZOG
DL5
DRFUL
DRSTM
DU5
DUUFO
EBD
EBS
ECM
EIF
EJD
EMOBN
EN4
EPAXT
ESBYG
F5P
FEDTE
FIGPU
FNLPD
FRRFC
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GQ6
GQ7
GQ8
GRRUI
GXS
H13
HF~
HG5
HG6
HGLYW
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
ITM
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
KDC
KOV
KOW
KPH
LAK
LATKE
LEEKS
LYRES
M1P
M4Y
MA-
MEWTI
MXFUL
MXSTM
N2Q
NB0
NDZJH
NPM
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
P2P
P2W
P9S
PF0
PQQKQ
PROAC
PSQYO
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RNI
ROL
RPX
RRX
RSV
RZC
RZE
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAMSI
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SMD
SNE
SNX
SOJ
SPISZ
SSXJD
SUPJJ
SV3
SZ9
SZN
T13
T16
TEORI
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
VC2
W23
W48
WH7
WJK
WK6
WK8
WXSBR
X7M
YLTOR
Z45
Z7U
Z7W
Z82
Z87
Z8O
Z8Q
Z8V
Z91
ZGI
ZMTXR
ZOVNA
ZZTAW
~EX
~KM
ID FETCH-LOGICAL-c4188-bbd7a4f6e4d0450bd0d56da592244b777a1537d320b99416f0c03f4fb4ce7fec2
ISSN 0141-8955
IngestDate Wed Oct 16 00:48:09 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4188-bbd7a4f6e4d0450bd0d56da592244b777a1537d320b99416f0c03f4fb4ce7fec2
PMID 8412012
ParticipantIDs pubmed_primary_8412012
PublicationCentury 1900
PublicationDate 1993-01-01
PublicationDateYYYYMMDD 1993-01-01
PublicationDate_xml – month: 01
  year: 1993
  text: 1993-01-01
  day: 01
PublicationDecade 1990
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of inherited metabolic disease
PublicationTitleAlternate J Inherit Metab Dis
PublicationYear 1993
SSID ssj0009855
Score 1.7860556
SecondaryResourceType review_article
Snippet Concentrations of organic acids in cerebrospinal fluid (CSF) appear to be directly dependent upon their rate of production in the brain. There is evidence that...
SourceID pubmed
SourceType Index Database
StartPage 648
SubjectTerms Amino Acids - cerebrospinal fluid
Animals
Blood-Brain Barrier - physiology
Brain - metabolism
Carboxylic Acids - cerebrospinal fluid
Humans
Metabolism, Inborn Errors - cerebrospinal fluid
Title Physiology and pathophysiology of organic acids in cerebrospinal fluid
URI https://www.ncbi.nlm.nih.gov/pubmed/8412012
Volume 16
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LSsQwFA0-UNyIT3yThTuptJ0kbZYq6iDoRgV30iQ3MOA8GDsbv96bJmPbUfGxKSUppe05TU-Te88l5FhBIRId8yjXICNn4BUpqVlkmFLc6ByEj7a4E91HdvPEn-rJnCq7pFSn-u3LvJL_oIptiKvLkv0Dsh8nxQbcR3xxiwjj9lcYV-GbtYmSqy48HNVtqAN90SZ9Uuiej3zVMMa_YFcsxMlQ-zLptSp13jSNJFxqoBOkfSiRKs4Ne2Y5pzu0th-qLF_XMcK3gN_a6GyC1_06LaZZT-WUbm3-XLgl5XbNr_vJuARoRDGakJ3XaUxGTOcnkyiX3nn3Y4AVDSKxxmgpvMnmp1E8nsamo_5Jctk6CBEY9Ss8c5agekl_7Jzx0w4982Q-y93AeOemd6YuzTkPMa_-Ltp-tuFqVshSOMfMr0glSR7WyGrAip55YqyTORhskOXbEC2xSa5qflDkB53hBx1aGvhBK37Q3oC2-EErfmyRx6vLh4tuFOpmRJol-IooZbKCWQHMoGCPlYkNF6bgEuUaU1mWFfiZy0wnjZWUKMhtrOOOZVYxDZkFnW6ThcFwADuExpBYmYBMpMFekRZFWljlZA_nAnhnl2z7J_A88uYoz-HR7H3XsU9WauIckEWL7yIcorAr1VEFxjvqAU2e
link.rule.ids 783
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Physiology+and+pathophysiology+of+organic+acids+in+cerebrospinal+fluid&rft.jtitle=Journal+of+inherited+metabolic+disease&rft.au=Hoffmann%2C+G+F&rft.au=Meier-Augenstein%2C+W&rft.au=St%C3%B6ckler%2C+S&rft.au=Surtees%2C+R&rft.date=1993-01-01&rft.issn=0141-8955&rft.volume=16&rft.issue=4&rft.spage=648&rft_id=info:doi/10.1007%2FBF00711898&rft_id=info%3Apmid%2F8412012&rft_id=info%3Apmid%2F8412012&rft.externalDocID=8412012
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0141-8955&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0141-8955&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0141-8955&client=summon